Our history
Allegra (authorized in Egypt as Telfast®), is a pioneering second generation antihistamine.1 Since 19962, our non-drowsy formula has enabled allergy sufferers to lead alert, fulfilling lives.1
Children's Telfast® for kids delivers effective, non‐sedating, 12‐hr relief in white uniform aqueous
suspension with a raspberry cream flavor.1
Find your Children's Telfast®
1996
The launch of Allegra (authorized in Egypt as Telfast®)
Once approved by the FDA in 1996, fexofenadine is brought to market as a prescription treatment of allergies as Allegra2
2017
Telfast® gets OTC approval
In 2017,Egyptian drug Authority approves Telfast® for over-the-counter sales in Egypt
Our cause
Telfast® fights the inequality of air quality.3
Did you know that the quality of air aggravates the existing symptoms of allergies? Polluted air exposes allergy sufferers to a wide range of health risks, including severe allergies.1 Telfast® recognises and aims to combat this inequality in air quality1 to sustain the health and comfort of all people, no matter where they live.
Why do we fight air pollution?
1. Telfast® 120 mg tablets. Egyptian drug Authority Approved Leaflet, approval date: 25/06/2023
2. FDA label.Fexofenadine approval.Available at : https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/201373Orig1s000OtherR.pdf ; Last accessed 29.8.2024
3. Allergy & asthma network.Indoor Air Quality and Indoor Air Pollution. Available at:https://allergyasthmanetwork.org/indoor-air-quality/ ;Last accessed 29.8.2024
4. Ellis AK, Murrieta-Aguttes M, Furey S, Picard P, Carlsten C. Effect of fexofenadine hydrochloride on allergic rhinitis aggravated by air pollutants. ERJ open research. 2021 Apr 1;7(2).
5- Li S, Wu W, Wang G, Zhang X, Guo Q, Wang B, Cao S, Yan M, Pan X, Xue T, Gong J. Association between exposure to air pollution and risk of allergic rhinitis: a systematic review and meta-analysis. Environmental research. 2022 Apr 1;205:112472.
6. State of Global air.Impact of Air Pollution on Life Expectancy.Available at:https://www.stateofglobalair.org/health/life-expectancy;Last accessed 29.8.2024
7. Cecchi L, D'Amato G, Annesi-Maesano I. External exposome and allergic respiratory and skin diseases. Journal of Allergy and Clinical Immunology. 2018 Mar 1;141(3):846-57.